Lifetime risk of dementia after age 55 is double previous estimates - White House and Illegal Drug Use by Musk and Trump. Alzheimer and Dirty Electricity. What is the connection? Tests on RATS confirm how we are getting Alzheimers, no HUMAN studies

A man does not sin by commisson only - but often by omission. - Marcus Aurelius

Music: Baha Men - Who Let The Dogs Out (Lyrics) (youtube.com)

Do you have a psychopath in your life? The best way to find out is read my book. BOOK *FREE* Download – Psychopath In Your Life4

Support is Appreciated: Support the Show – Psychopath In Your Life

You need to turn your phone's Face ID and thumbprint lock off ASAP. (youtube.com)

Incidence of Dementia over Three Decades in the Framingham Heart Study | New England Journal of Medicine (nejm.org)

Want Better Health and Status? For $250,000, Longevity Clinics Promise Both - WSJ

Peter Thiel's Antiaging Routine As a 56-Year-Old Billionaire - Business Insider

Amid all the warnings about a 'dementia tsunami', here are the things you should know | Devi Sridhar | The Guardian

H.R.372 - 119th Congress (2025-2026): Drug Testing for Welfare Recipients Act | Congress.gov | Library of Congress

The risk of dementia is much higher than experts thought - MarketWatch

Odds of Alzheimer's diagnoses vary by region (axios.com)

As baby boomers turn 80, there aren't enough doctors to treat 'emergency levels' of dementia patients - MarketWatch

Expected and diagnosed rates of mild cognitive impairment and dementia in the U.S. Medicare population: observational analysis | Alzheimer's Research & Therapy | Full Text (biomedcentral.com)

Dementia and disadvantage in the USA and England: population-based comparative study - PMC (nih.gov)

NEW: Psychopath In Your Life Iraq Plutonium and DNA destruction – Psychopath In Your Life

My file on how hormones work. https://psychopathinyourlife.com/CRD/

The Stolen Children Project – Psychopath In Your Life

Timeline and History of Ruling Class – Psychopath In Your Life

WHO are the Royal Monsters running the World? – Psychopath In Your Life

Timeline of Eugenics "Natural" Disasters – Psychopath In Your Life

Psychopath In Your Life – Dianne Emerson – YouTube

Tune in: Podcast Links – Psychopath In Your Life

BOOK *FREE* Download – Psychopath In Your Life

TOP PODS – Psychopath In Your Life

Google Maps My HOME Address: 309 E. Klug Avenue, Norfolk, NE 68701 SMART Meters & Timelines – Psychopath In Your Life

Several key animal and laboratory studies showing that EMF exposure can disrupt the blood-brain barrier (BBB)—potentially enabling harmful substances like beta-amyloid to enter the brain.

• Salford et al. and Follow-up (1994, 2008)

Study: Rats exposed to 915 MHz microwaves (continuous and pulsed) for 2 hours.

Finding: Leakage of albumin into brain tissue—a clear sign of BBB disruption

Result: 56 of 184 exposed rats showed albumin leakage versus 5 of 62 controls

• Rahman et al. (2008)

Study: Male and female Wistar rats exposed to 0.9 and 1.8 GHz RF (20 minutes, under anesthesia).

Finding: Only male rats showed significant albumin (BBB) leakage—no effect in females.

• Eberhardt et al. (2007)

Study: GSM-900 (mobile phone) radiation exposure.

Finding: Persistent albumin extravasation—both immediately and 7 days after a 2-hour exposure. Effects seen even at low power (0.12 mW/kg).

• Electromagnetic Pulse (EMP) Study

Study: Sprague–Dawley rats exposed to 100–10,000 pulses of EMP (50 kV/m, 100 Hz).

Finding: Led to cognitive impairment, oxidative stress, and increased beta-amyloid formation.

Ultra-Wide-Band Pulses (2020)

• Study: Rats exposed to broad-spectrum EM pulses.

Finding: Increased BBB permeability noted—tight-junction protein expression and other markers were altered.

• Review of RF EMF Effects on BBB (2010)

Finding: BBB permeability increases only when tissue heating >1 °C; evidence for non-thermal RF effects remains inconclusive or mixed.

Connection to Beta-Amyloid & Alzheimer's

EMP exposure not only disrupts the BBB but also elevates amyloid‑β precursor and oligomer proteins.

Once BBB integrity is compromised, beta‑amyloid—central to Alzheimer's pathology—may more easily accumulate in brain tissue.

Study Exposure Effect on BBB Amyloid/Biomarkers Salford et al. 915 MHz, 2h Albumin leakage N/A Rahman et al. 0.9/1.8 GHz, 20min Male rats only albumin N/A Eberhardt et al. GSM-900, 2h Albumin leakage up to 7 days N/A EMP pulses 50 kV/m pulses Cognitive decline, oxidative stress ↑ Aβ protein UWB pulses Ultra-wide EM pulses Increased permeability, protein changes N/A 2010 review RF field overview Thermal BBB breakage possible; non-thermal is unclear

• Animal models strongly suggest BBB disruption occurs with certain EMF exposures, particularly at cellular phone frequencies and electromagnetic pulses.

• This disruption may enable beta-amyloid infiltration and accumulation, a known factor in Alzheimer's disease pathology.

• However, BBB effects from low-intensity or daily-life EMFs (non-thermal) remain less certain and disputed.

Does Dirty Electricity Contribute to Alzheimer's?

Possible Biological Mechanisms (Proposed in Studies):

• BBB Disrupted Repeated EMF exposure—especially in higher or pulsed frequencies—has been shown in animal studies to compromise the blood-brain barrier (BBB).
• This could allow beta-amyloid, toxins, and inflammatory agents to enter the brain.
• Oxidative Stress & Neuroinflammation:
• Studies on both EMFs and dirty electricity suggest they can generate reactive oxygen species (ROS) in brain tissue, contributing to neurodegeneration.
• Circadian Disruption & Melatonin Suppression:
• EMFs, including those from smart meters, may interfere with melatonin—an important antioxidant that protects neurons and regulates sleep.
• Electrohypersensitivity (EHS)
• Though controversial, some individuals report memory loss, confusion, and brain fog in proximity to smart meters or high-DE environments. These symptoms are consistent with cognitive decline markers.

Do Countries with Smart Meters Show More Dementia?

Not Conclusively Proven, but correlations are being observed:

• High smart meter and Wi-Fi saturation countries (USA, UK, parts of Europe, Australia) also report rising early-onset dementia.
• But these same countries also have:
• Older populations
• More screening
• Better reporting systems

So while correlation exists, causation hasn't been proven.

Example Comparison (Approximate):

Country Smart Meter Rollout Dirty Electricity Concerns Alzheimer's Prevalence (65+) USA ~80% of homes High; solar, Wi-Fi, smart tech ~11% (CDC, 2023) UK >50% rollout Similar issues ~7.1% (Alzheimer's Society) Japan Extensive rollout High population density EMF ~7.3% India Low rollout Lower DE, but more pollution ~1.5–2% (underreported) Rural Africa Minimal tech Low EMF

What Is Still Needed

• Longitudinal studies directly comparing high-smart-meter/DE regions to controls.
• Controlled human or animal studies using simulated DE conditions.
• Research on cumulative lifetime exposure to DE and early-onset Alzheimer's (

Bottom Line

• The biological mechanisms for a link exist and are plausible.
• Dirty electricity and smart meter EMFs could plausibly exacerbate Alzheimer's risks, especially in vulnerable populations.
• But direct proof is lacking—this is a field that urgently needs independent epidemiological and toxicological studies.

Age-Specific Incidence and Prevalence Are Declining

A U.S. study conducted from 2000 to 2016 found that the prevalence of dementia dropped from 11.5% to 7.7%, indicating an approximate annual decline of 3%. During the same period, the incidence rate decreased from around 5% to 3.8%, representing a roughly 2% annual decline.

The Framingham Heart Study, which spanned from the 1970s to the 2010s, reported a 44% reduction in five-year dementia incidence. This decline was especially notable among individuals who had completed at least a high school education.

Across North America and Europe, between 1988 and 2015, dementia incidence declined by approximately 13% per decade.

Total Dementia Cases Are Rising Rapidly

Even though age-specific rates are falling, the overall number of dementia cases continues to rise due to the aging population in the United States. In 2020, approximately 7 million Americans aged 65 and older were living with dementia. This number is projected to exceed 9 million by 2030 and approach 12 million by 2040.

In 2018, Alzheimer's disease alone affected about 5.7 million people. Forecasts suggest that this figure will rise to 7.1 million by 2025 and nearly 13.8 million by 2050.

Mortality Rates and Death Certificates

Dementia-related mortality has increased significantly over the past two decades. The number of deaths associated with dementia tripled from approximately 150,000 in 1999 to over 450,000 in 2020.

This rise in reported dementia deaths is partly attributed to improved diagnosis and more accurate reporting on death certificates.

Why This Paradox? Factor Impact Better Education & Vascular Care Reduced risk per individual; lower incidence Health Improvements Fewer vascular events; decline in smoking Population Aging Largest driver of absolute increases in dementia cases Reporting & Diagnosis More cases being recognized and recorded due to improved practices Projections and Future Risk

Data recent lifetime risk of dementia after age 55 in the U.S. is now estimated at 42%, an increase from previous estimates. Projections also indicate that annual new dementia cases are expected to double, rising from approximately 514,000 cases in 2020 to nearly 1 million cases by 2060. Despite the alarming increase in total case numbers, age-specific incidence rates of dementia continue to decline, signaling a positive trend in individual risk reduction.

On an individual level, fewer older adults are developing dementia today compared to two decades ago. This progress is largely attributed to improvements in education, healthcare, and lifestyle factors such as better vascular health and reduced smoking.

However, due to the aging population and enhanced detection methods, the absolute number of people living with dementia continues to grow. Even if individual risk remains on a downward trend, the U.S. and other aging societies should expect millions more dementia cases in the coming decades.

International Comparison

Prevalence and Incidence Rates

Dementia prevalence among individuals aged 65 and older is notably higher in the United States at approximately 11.2%, compared to about 9.7% in England, according to recent data.

Across OECD countries, 2021 figures indicate an average dementia prevalence of roughly 15 per 1,000 people, or 1.5% of the general population. This rate varies depending on each nation's age structure and healthcare infrastructure.

Regional and National Differences

High-Income Asia

Japan currently holds the highest dementia prevalence among high-income countries, with about 3,079 cases per 100,000 people (roughly 3.08%). This was highlighted in a recent report examining neurological disease trends in East Asia.

In China, the prevalence is significantly lower—around 924 per 100,000 (0.92%)—but the sheer size of the elderly population contributes to a substantial national health burden. Countries such as India and Brazil are also seeing a notable rise in dementia cases due to their shifting demographics.

Europe

In Western Europe, dementia rates among seniors range from 1.8% to 3.1%, based on findings from a study examining multiple European populations. Specifically, countries like Sweden, Italy, and Germany report rates between 1.86% and 1.96% among older adults.

Trends Over Time

Between 1988 and 2015, the incidence of dementia—measured as new age-adjusted cases per year—declined by about 13% per decade in both the U.S. and Europe. Furthermore, recent trends show that younger generations in countries such as the U.S., U.K., and across Europe are developing dementia later in life compared to earlier cohorts. This reflects improvements in preventive health measures and overall well-being.

Overall Context and Implications

The absolute number of dementia cases is highest in regions with aging populations. For example, in North America, approximately 5.1 million individuals aged 60 and older were living with dementia in 2020, with projections reaching 9.2 million by 2040. Although age-specific dementia rates are lower in populations with better education, healthcare, and lifestyle behaviors, the overall case numbers continue to rise due to demographic aging.

In the United States, socioeconomic disparities further complicate the picture. Lower-income groups experience significantly higher dementia prevalence compared to wealthier groups. This inequality is more pronounced than in countries like England, where stronger social support systems help mitigate risk.

Key Takeaways

The United States currently has similar or slightly higher age-related dementia rates compared to other developed countries. While individual risk is decreasing—thanks to advances in public health and preventive care—the total number of dementia cases continues to increase due to an aging population. Japan currently leads in per-capita dementia prevalence, while other high-income regions, including parts of Europe and North America, closely follow.

Importantly, economic inequality in the U.S. appears to magnify dementia risk, especially when compared to countries with more robust social welfare systems like the U.K.

Prevalence in High-Income Countries (per 1,000 population, all ages)

Based on OECD and IHME data (2021):

Dementia Prevalence by Country/Region Country / Region Prevalence per 1,000 % of Population Japan ~30.8 3.08 % Italy ~22.7 2.27 % Germany ~18.6 1.86 % USA ~15.0* 1.50 % UK ~14.0* 1.40 % Canada ~15.6 1.56 % Australia ~13.2 1.32 %

U.K. and U.S. rates are comparable, with the U.K. slightly lower. Australia also sits below these averages.

Incidence Trends Over Time (Age-Adjusted)

Between 1988 and 2015, both the United States and Europe experienced a 13% decline per decade in age-standardized dementia incidence. A 2025 study across the U.S., U.K., and Europe further confirms that younger generations show lower dementia prevalence at similar ages compared to older cohorts. Global studies reinforce this trend, indicating that age-adjusted dementia rates are declining worldwide, even as the total number of cases rises due to population aging.

Total Cases and Projections

According to 2021 data from the OECD, there were approximately 21 million people living with dementia across member countries. This number is projected to increase to around 32 million by 2040. In the United States, about 5 million people are currently living with Alzheimer's disease, and the trajectory is expected to mirror trends seen in other high-income nations. Globally, the dementia burden has more than doubled—from 20 million in 1990 to 52 million in 2019—with high-income regions continuing to account for the majority of cases.

Key Takeaways

The United States' age-adjusted dementia rates are comparable to, or slightly higher than, those in peer countries such as the United Kingdom, Canada, and Australia, though still below levels reported in Japan and Italy. Across high-income countries, the individual risk of developing dementia is declining, largely due to improved education, cardiovascular health, and healthier lifestyles.

However, the total number of dementia cases continues to increase, primarily driven by demographic aging and longer life expectancies. In the U.S., these trends are complicated by stark socioeconomic disparities. Dementia rates are significantly higher among lower-income and underserved populations, with the gap being wider than in countries with stronger social support systems.

Insights

The United States faces a substantial dementia burden, on par with other aging and affluent societies. The good news is that individual risk is on the decline. However, the public health challenge remains significant due to the growing number of older adults. Additional efforts focusing on health equity and prevention could help narrow the disparity gap seen in the U.S.

Global Snapshot

As of 2020, approximately 55 million people around the world were living with dementia. Over 60% of these individuals were in low- and middle-income countries (LMICs), a figure that is projected to rise to 70% by 2050. Globally, about 10 million new dementia cases occur each year—equating to roughly one new case every three seconds.

Prevalence in LMICs vs. High-Income Countries (HICs)

In 2019, the prevalence of dementia among adults aged 65 and older was estimated at about 9% in high-income countries and 5% in low-income countries. While the prevalence in LMICs is currently lower, it is rising quickly with aging populations.

Importantly, studies using culturally sensitive diagnostic methods—such as the 10/66 criteria—suggest that actual dementia rates in LMICs may be 1.5 to 2.5 times higher than standard DSM-based estimates.

Trends in LMICs

In Latin America, dementia prevalence increased significantly between 2003 and 2019. In Mexico, for example, rates rose from 8.3% to 17.1%. Peru experienced a rise from 9.2% to 16.8%, and similar trends were observed in the Dominican Republic. In Sub-Saharan Africa, reported dementia prevalence varies widely, ranging from 2.3% to 10.1%, largely due to inconsistencies in diagnostic practices.

Awareness, Stigma, and Care Challenges

In many communities within LMICs, dementia is not widely recognized as a medical condition, which leads to social stigma. In Nigeria, for example, dementia is sometimes misinterpreted as witchcraft. Underdiagnosis is a major issue, with up to 90% of dementia cases in LMICs going undiagnosed.

The care infrastructure in these regions is also severely limited. Only eight countries globally have adopted national dementia plans, and most of them are high-income nations. The economic burden in LMICs is further compounded by the fact that informal caregiving accounts for about 65% of dementia-related costs, compared to more institutional and social support services in wealthier countries.

Projections for Developing Countries

Dementia cases in low- and middle-income countries are expected to nearly triple by 2050, particularly in regions such as Asia and Latin America. Without significant investments in early detection, prevention, and care infrastructure, these areas will face an overwhelming increase in prevalence and associated needs.

Prevalence in Ages 65+ (HRS/ADAMS Cohorts & RAND Analysis) Year Prevalence (%) 2000 11.6 % 2004 ~11.1 % (gradual decline) 2008 ~10.3 % 2012 8.8 % 2016 7.7 %

• From 2000 to 2012: ~2.8 percentage-point drop (11.6 % → 8.8 %)
• From 2000 to 2016: ~3.9 percentage-point drop (11.6 % → 7.7 %)

Incidence in Ages 65+ (Based on HRS Data)

Between 2000 and 2002, the annual dementia incidence rate among U.S. adults aged 65 and older was approximately 5.0%. By the 2014–2016 period, that rate had declined to around 3.8%, marking a total decrease of about 24%. This represents an average annual decline of roughly 2%.

Summary of Trends

From 2000 to 2016, dementia prevalence declined by about 3 percentage points, or roughly 30%. Similarly, incidence dropped by approximately 24% over the same period. These downward trends suggest improvements in public health—particularly in healthcare access, education, and lifestyle behaviors. Notably, these gains occurred despite the increasing prevalence of conditions like hypertension, obesity, and diabetes.

Total Number of Cases Still Rising

Although the percentage of older adults with dementia may be stabilizing or slightly declining in some regions, the total number of cases continues to rise significantly due to an aging population. In 2020, approximately 7 million Americans aged 65 and older were living with dementia, according to projections published in The Lancet, the Population Reference Bureau (PRB), and AP News.

Looking ahead, the total is projected to exceed 9 million by 2030 and reach around 12 million by 2040, as outlined in long-range demographic models from PRB.

Focusing on Alzheimer's disease specifically, the number of cases is expected to increase from 6.07 million in 2020 to approximately 7.16 million by 2025, based on forecasts published in the Alzheimer's Association journal.

What This Reveals

The data demonstrates two important realities. First, individual risk is decreasing—fewer older adults are developing dementia each year. Second, the population impact is increasing, simply because there are more older adults overall. While public health improvements have clearly reduced per-person risk, the demand for dementia care and support services is intensifying as absolute case numbers grow.

Closing Thoughts

Between 2000 and 2016, there was steady and measurable progress in reducing both dementia prevalence and incidence among older adults in the United States. Nevertheless, the total number of dementia cases continues to climb due to population aging. This dual trend—lower risk per person but more people affected overall—is at the core of the dementia burden today.

Studies such as the Health and Retirement Study (HRS) and the Framingham Heart Study consistently show that fewer people aged 65 and older are developing dementia each year. Age-adjusted rates for both prevalence and incidence have declined by approximately 24–30% during the early 2000s to mid-2010s period.

Why Are Dementia Rates Declining Per Person?

Several contributing factors have likely driven the downward trend in age-specific dementia rates:

• Higher levels of education across generations
• Improved heart health, including better hypertension management and reduced smoking
• Possible increases in brain health and cognitive reserve

These factors reflect a broader pattern of public health advancement, especially in higher-income countries.

Total Dementia Cases Are Increasing Rapidly

While individual risk has decreased, the aging of the U.S. population has led to a sharp rise in total dementia cases. In 2000, approximately 35 million Americans were aged 65 and older. By 2024, that number had grown to roughly 62 million. Even with a lower dementia rate per 100 people, the dramatic increase in the size of the elderly population results in a higher absolute number of dementia cases.

To illustrate, about 7 million Americans had dementia in 2020. Projections indicate this number will exceed 9 million by 2030 and reach more than 12 million by 2040. Furthermore, deaths from Alzheimer's disease have tripled from 1999 to 2020—a trend partly driven by aging and partly by improved diagnostic recognition.

Understanding "Higher Than Expected" Headlines

Media headlines stating that "dementia risk is higher than previously thought" or warning of a "dementia tsunami" often refer to newer, more comprehensive estimates. For example, recent research suggests that the lifetime risk of developing dementia after age 55 may be as high as 42%, significantly more than older projections.

In addition, some studies indicate earlier onset in specific groups, including military veterans, individuals with traumatic brain injuries, and certain racial and ethnic populations. New research also points to emerging risk factors, such as obesity, air pollution, PTSD, and diabetes—all of which are becoming more prevalent and may contribute to higher dementia risk in the future.

Understanding Dementia Trends Statement True? Meaning "Dementia rates are declining" Yes On a per-person, age-adjusted basis, fewer people are getting it "Dementia numbers are increasing" Yes The total population is older, so there are more total cases "Risk is higher than expected" Sometimes New methods suggest more people over a lifetime may develop it than previously estimated What Is "Dirty Electricity"?

"Dirty electricity" (DE) refers to high-frequency voltage transients (HFVTs) and electromagnetic interference (EMI) that travel along power lines. These disturbances are caused by devices such as smart meters, LED lights, dimmer switches, switching power supplies, and Wi-Fi routers. Dirty electricity represents a form of low-level, non-ionizing radiation, which is distinct from ionizing radiation like X-rays or gamma rays.

Alzheimer's Disease

Alzheimer's disease is a progressive and irreversible brain disorder that gradually destroys memory, thinking skills, and eventually the ability to perform simple tasks. It is the most common cause of dementia among older adults.

Medical Definition

Alzheimer's is a neurodegenerative disorder characterized by the buildup of amyloid-beta plaques and tau tangles in the brain. These pathological changes lead to neuronal loss, brain atrophy, and a decline in cognitive functions.

Key Features

Early symptoms include memory loss, especially affecting short-term memory. As the disease progresses, individuals may experience disorientation and confusion about time and place, language difficulties such as trouble finding words, poor judgment, personality changes, and mood swings. In advanced stages, full-time care becomes necessary.

Biological Markers

The disease is marked by several biological indicators:

• Amyloid-beta plaques: Sticky protein clumps that accumulate between neurons.
• Tau tangles: Twisted strands found inside brain cells.
• Brain shrinkage (atrophy), especially in the hippocampus.
• Neuroinflammation and oxidative stress.

Diagnosis

There is no single definitive test for Alzheimer's. Diagnosis typically involves a combination of medical history review, cognitive assessments, brain imaging techniques like MRI and PET scans, cerebrospinal fluid (CSF) analysis for biomarkers, and emerging blood tests for new biomarker indicators.

Stages of Alzheimer's

• Preclinical: Brain changes start decades before symptoms appear.
• Mild Cognitive Impairment (MCI): Subtle memory problems emerge.
• Mild Alzheimer's: Noticeable memory loss and confusion begin.
• Moderate: Confusion worsens, and assistance with daily activities is needed.
• Severe: The individual loses the ability to communicate or care for themselves.

Alzheimer's Disease vs. Dementia

While often used interchangeably, Alzheimer's disease and dementia are not the same.

Dementia describes a general decline in cognitive abilities severe enough to interfere with daily life. It is not a specific disease but a syndrome, a group of symptoms affecting memory, reasoning, language, judgment, and behavior. There are many different causes of dementia, with Alzheimer's being the most common.

Alzheimer's: A Specific Disease Under the Dementia Umbrella

Alzheimer's disease is the most common cause of dementia, accounting for 60–80% of cases.

So:

• All Alzheimer's is dementia

• But not all dementia is Alzheimer's

Other Types of Dementia Include: Dementia Type Key Characteristics Alzheimer's Gradual memory loss, confusion, disorientation Vascular dementia Caused by strokes or reduced blood flow to the brain Lewy body dementia Hallucinations, Parkinson-like symptoms Frontotemporal dementia Personality and language changes before memory loss Mixed dementia A combination, often Alzheimer's plus vascular dementia Parkinson's dementia Develops in the later stages of Parkinson's disease Dementia vs. Alzheimer's Disease Feature Dementia Alzheimer's What it is Symptom cluster (syndrome) Specific brain disease Causes Many (including Alzheimer's) One specific cause Reversible types? Sometimes (e.g., from vitamin deficiency) No (Alzheimer's is irreversible) Main effect Cognitive decline Progressive memory loss and co Is There a Link Between Dirty Electricity and Dementia?

Currently, there is no definitive scientific consensus within the mainstream medical community that directly links dirty electricity to Alzheimer's disease or dementia. However, some independent researchers and proponents of alternative health science suggest there may be connections worth exploring.

These researchers propose that prolonged exposure to certain electromagnetic frequencies (EMFs) could trigger brain inflammation. They also suggest that EMF exposure may lead to mitochondrial dysfunction and oxidative stress, which could impair cognitive function over time. While some case studies and ecological research have noted a correlation between high-EMF environments and increased rates of dementia or other neurological disorders, these studies do not establish causation.

Studies of Interest

One study by Havas and Olstad (2008) observed that filtering dirty electricity in classrooms was associated with improvements in children's behavior and cognitive performance. However, this study was small in scale and remains controversial within the scientific community.

The BioInitiative Report, compiled and updated between 2007 and 2020, presents a collection of research suggesting that low-level EMF exposure could be linked to neurological and other health effects. While widely cited by advocacy groups, this report is not peer-reviewed in the traditional academic sense.

In addition, studies conducted in countries such as Switzerland, Israel, and Iran have identified certain biological responses to EMF exposure—such as increased permeability of the blood-brain barrier—that could potentially contribute to cognitive issues over time.

What Do Mainstream Institutions Say?

Leading health organizations like the World Health Organization (WHO), the National Institutes of Health (NIH), and the Centers for Disease Control and Prevention (CDC) maintain that there is no conclusive evidence that low-level EMFs, including those from dirty electricity, are a cause of dementia.

The International Agency for Research on Cancer (IARC) classifies electromagnetic fields as Group 2B carcinogens. This means they are considered "possibly carcinogenic to humans," based on limited evidence. However, the IARC's classification largely focuses on higher-frequency EMF exposures, such as those from mobile phones, rather than low-frequency transients from power lines and electrical devices.

Cognitive Effects and EMFs: A Broader Perspective

Although a direct link between EMF exposure and dementia is unproven, there are broader concerns about cognitive health. Some individuals report symptoms attributed to EMF hypersensitivity, such as memory problems, confusion, and headaches. These symptoms, while real to those experiencing them, are not officially recognized as being related to dementia.

Animal studies have also indicated that chronic EMF exposure might affect memory and hippocampal function, suggesting that further research could be warranted to understand potential long-term cognitive effects.

Evaluating Claims About Dirty Electricity and Dementia Claim Status Dirty electricity might impair cognitive health Theoretical / weak evidence Dirty electricity causes Alzheimer's or dementia Not proven Chronic EMF exposure increases oxidative stress or inflammation Some support in lab and animal studies Total dementia rates increasing is due to EMF exposure Unproven correlation, not established causation 1. 900 MHz EMF Exposure in Adolescent Rats

Design: Male Sprague-Dawley rats were exposed to 900 MHz electromagnetic fields (a common cell phone frequency) for one hour per day throughout adolescence.

Findings: At 60 days, the exposed rats exhibited pyramidal neuron loss, increased oxidative stress (evidenced by elevated malondialdehyde and decreased catalase levels), and damage to the hippocampus. These outcomes suggest a potential impairment in memory formation.

2. Extremely Low-Frequency EMF (ELF-EMF) and Spatial Memory in Adult Rats

Design: Adult rats were subjected to ELF-EMF ranging from 1 to 2000 µT for two hours daily over a period of 60 days.

Findings: The exposure altered behavioral patterns, particularly affecting spatial memory retention and anxiety responses. Additionally, there was a measurable increase in oxidative stress markers in the brain.

3. Chronic Exposure to 1,950 MHz RF-EMF in Mice

Design: C57BL/6 mice received exposure to 1,950 MHz radiofrequency EMF for two hours a day, five days a week, over eight months.

Findings: The mice demonstrated impairments in both spatial and recognition memory. There were also significant changes in hippocampal gene expression related to neurogenesis, indicating possible long-term cognitive effects.

4. 916 MHz EMF Exposure and Radial-Arm Maze Performance in Rats

Design: Rats were exposed to 916 MHz EMF for six hours a day, five days per week, over a 10-week period.

Findings: Around weeks four and five of the study, exposed rats completed maze tasks more slowly and with more errors. Abnormal firing patterns in hippocampal neurons were also observed. However, some level of adaptation was noted later in the exposure period.

5. EMF Exposure and Kindling Stress in Rats

Design: In a seizure-prone rat model using hippocampal kindling, rats were exposed to 100 Hz EMF for one hour daily over the course of a week.

Findings: Surprisingly, EMF exposure restored learning and memory functions in the kindled rats and helped normalize long-term potentiation (LTP) in the hippocampus. These results suggest that EMF effects may be context-dependent and potentially therapeutic in certain neurological states.

6. 5G-Band (~2.65 GHz) EMF Exposure in Mice

Design: Mice were exposed to simulated 5G electromagnetic fields at 2.65 GHz for four hours a day over 28 days.

Findings: Exposure led to anxiety-like behaviors and a decrease in hippocampal brain-derived neurotrophic factor (BDNF) expression, indicating stress-related neurological effects.

7. ELF-EMF Exposure in Alzheimer's Model Rats

Design: Rats genetically modified to mimic Alzheimer's disease were exposed to ELF-EMF at 50 Hz and 400 µT for 60 days.

Findings: The EMF exposure improved spatial memory performance and reduced pathological markers in the hippocampus. These findings suggest possible therapeutic potential of EMF in neurodegenerative models.

EMF Exposure Studies on Rodents Study Frequency / Exposure Impact on Hippocampus / Memory 900 MHz in adolescent rats Cell phone frequency, 1 hr/day Increased oxidative stress, neuron loss ELF-EMF in adult rats 1–2000 µT, 2 hrs/day Altered anxiety levels, impaired memory retention, elevated oxidative markers 1,950 MHz in mice 2 hrs/day, 5 days/week, 8 months Impaired spatial and recognition memory, changes in hippocampal gene expression 916 MHz in rats 6 hrs/day, 5 days/week, 10 weeks Temporary decline in maze performance, abnormal neuron firing 100 Hz in kindling rats 1 hr/day for 1 week Restored long-term potentiation (LTP) and memory after seizures 2.65 GHz (5G) in mice 4 hrs/day, 28 days Increased anxiety-like behaviors, decreased hippocampal BDNF 50 Hz in Alzheimer's rats 400 µT, 60 days Improved memory, reduced hippocampal pathology Interpretation of EMF Exposure Findings

Research on electromagnetic field (EMF) exposure in animal models shows mixed results. In healthy animals, particularly those exposed to radiofrequency EMFs (RF-EMF), there is evidence of hippocampal damage and cognitive decline. However, in certain diseased models—such as rodents with Alzheimer's-like conditions—low-frequency EMF exposure has shown potential therapeutic effects, improving memory and brain function.

The biological mechanisms behind these effects include oxidative stress, neuronal damage, altered neuronal firing patterns, gene expression changes, and neuroinflammatory responses. Despite these findings, the relevance to human health remains uncertain due to key differences in species, exposure duration, intensity, and individual vulnerability.

Projected Growth in Alzheimer's and Cognitive Impairment

By 2060, it is projected that nearly 14 million Americans aged 65 and older will have clinical Alzheimer's disease. This represents an increase of over 128% compared to the 2020 estimate. Notably, the prevalence among Black and Hispanic older adults is expected to rise even faster, significantly shifting the demographic distribution of affected populations.

Prevalence of Mild Cognitive Impairment (MCI)

The same projections show that in 2020, around 12.23 million Americans were living with Mild Cognitive Impairment (MCI) of any type. By 2060, that number is expected to grow to approximately 21.55 million—a 76% increase.

When combining Alzheimer's and MCI figures:

• In 2020: 6.07 million with Alzheimer's plus 12.23 million with MCI, totaling approximately 18.3 million people.
• In 2060: 13.85 million with Alzheimer's plus 21.55 million with MCI, totaling around 35.4 million people.

Lifetime Risk and Annual Case Projections

According to a 2025 analysis featured in Nature Medicine and reported by Scientific American, the estimated lifetime risk of developing dementia after age 55 is now around 42%. This marks a significant increase from older estimates that ranged between 11% and 23%.

Annual new cases of dementia are also on the rise:

• Around 514,000 new cases per year in 2020
• Projected to reach 1 million new cases annually by 2060

Historic Projections and Additional Models

Earlier modeling, such as the 1998–2011 American Journal of Public Health study, predicted that Alzheimer's prevalence would nearly quadruple between 1997 and 2050, rising from 2.32 million to approximately 9–10 million. Current estimates from sources like the CDC and the Fisher Center align with projections of 13.8 to 14 million cases by 2050 to 2060.

Summary of Key Forecasts

• 2020: Approximately 6.1 million with Alzheimer's; around 12.2 million with MCI
• 2025: Estimated 7.2 million with Alzheimer's
• 2030: Projected 8.5 million with Alzheimer's
• 2040–2060: Estimates range from 11 to 14 million with Alzheimer's alone
• 2060: Over 13 million with Alzheimer's plus 21.5 million with MCI, totaling more than 35 million affected individuals
• Annual New Cases: Increasing from around 500,000 per year to 1 million by 2060

Why These Numbers Matter

Even if individual age-specific risk remains stable or declines slightly due to improved healthcare and lifestyle factors, the aging of the population ensures that the absolute number of dementia cases will continue to rise. With nearly half of adults over the age of 55 facing a lifetime risk of developing dementia, the strain on healthcare systems, caregivers, and public health infrastructure is set to intensify.

Understanding these projections emphasizes the urgent need for enhanced prevention strategies, expanded care infrastructure, and targeted research into causes and treatments.

Hypothesized Mechanisms Linking EMFs / Dirty Electricity to Alzheimer's

While there is no definitive clinical proof, researchers have proposed several biological mechanisms:

1. Chronic Brain Inflammation

Exposure to electromagnetic fields (EMFs) has been shown to increase glial cell activation and elevate levels of neuroinflammatory cytokines in animal studies involving rats and mice. Chronic inflammation is widely recognized as a central feature of Alzheimer's disease pathology, and ongoing neuroinflammation may accelerate neuronal damage and cognitive decline.

2. Blood-Brain Barrier (BBB) Disruption

Several EMF studies suggest that exposure can lead to a breakdown of the blood-brain barrier (BBB). This disruption may allow harmful substances, including toxins and proteins such as beta-amyloid, to enter the brain more freely.

The accumulation of beta-amyloid in brain tissue is a hallmark of Alzheimer's disease and may be exacerbated by compromised BBB integrity.

3. Oxidative Stress and Mitochondrial Dysfunction

EMF exposure has also been linked to increased oxidative stress and damage to neuronal mitochondria. Mitochondria are essential for cellular energy production, and their dysfunction can impair brain function. Brains affected by Alzheimer's disease consistently show elevated levels of oxidative stress, suggesting a possible connection between EMF-induced cellular damage and cognitive decline.

4. Melatonin Suppression

EMFs are known to reduce the body's production of melatonin, a hormone primarily released during sleep. Melatonin plays several protective roles in the brain: it acts as a powerful antioxidant, supports neuronal health, and helps to clear beta-amyloid buildup. A deficiency in melatonin may therefore contribute to increased vulnerability to neurodegenerative processes.

5. Calcium Channel Disruption

Research indicates that EMFs may disrupt voltage-gated calcium channels (VGCCs), which are essential for proper neuronal signaling. When VGCCs are altered or overstimulated, it can lead to excessive calcium influx in neurons, triggering cell damage, oxidative stress, and ultimately memory loss. This disruption may represent another pathway through which EMFs contribute to neurodegeneration.

Studies That Support a Possible EMF–Brain Link

A number of independent studies suggest a potential association between electromagnetic field (EMF) exposure and adverse brain effects, though causality remains unconfirmed.

One foundational study by Salford et al. (2003) exposed rats to mobile phone radiation and observed leakage in the blood-brain barrier (BBB) as well as neuron damage in critical brain regions like the cortex and hippocampus. Havas (2006, 2013) found associations between "dirty electricity" and cognitive symptoms such as brain fog, headaches, and behavioral changes, particularly in school and home settings.

The BioInitiative Report (2007–2020), though not peer-reviewed in the conventional sense, compiled over 1,800 studies on EMF exposure, covering outcomes such as DNA damage, cognitive impairment, and neurodegeneration. In a related vein, Lai and Singh (1995–2004) documented increased DNA strand breaks in the brains of rats following RF (radiofrequency) radiation exposure.

Alzheimer's and EMF: A Potential Correlation?

Though a definitive causal link between EMF exposure and Alzheimer's disease has not been established, some ecological and epidemiological data suggest possible connections. For example, urban areas with high EMF densities have reported increased Alzheimer's prevalence. Similarly, elevated dementia risks have been observed among military radar operators and radio technicians—occupations with high long-term EMF exposure.

In community-level reports, people living near high-voltage power lines, cell towers, and smart meters have reported more frequent cognitive complaints, though these are often anecdotal and lack rigorous scientific control.

What's Missing in the Research?

Mainstream medical and scientific institutions remain cautious, emphasizing that current evidence is insufficient to prove causation between EMF exposure and dementia. However, the absence of proof does not equate to proof of absence.

A major limitation is that most research funding continues to focus on well-established Alzheimer's models—such as amyloid plaque buildup, tau pathology, and genetic risk factors. In contrast, studies exploring EMF-related mechanisms are frequently underfunded, small in scale, and inconsistently replicated. This leaves a gap in our understanding that prevents stronger conclusions.

Dementia Care Crisis as Baby Boomers Age

As the oldest baby boomers turn 80 in 2025, the U.S. medical system is already facing what some experts describe as "emergency levels" of demand for deme